// App-Quantinova.ai

386 : Optimal dose of intranasal dexmedetomidine for laceration repair in children: a phase II dose-ranging study using the continual reassessment method

Researchers

Presenter

  • Sarah Meulendyks

Principal Investigators

  • Holly Stevens

  • Amanda Chapman

  • Natalie Evans

  • Charlotte A. Mace

  • Christopher D. Creene

  • Shaily Brahmbhatt

  • Naveen Poonai

Medical Centers

  • The University of Western Ontario - Schulich School of Medicine & Dentistry, Kilworth, ON, Canada

  • London Health Sciences Centre, London, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Dexmedetomidine hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved